SPOTLIGHT -
Samantha Budd Haeberlein, PhD: The TANGO II Trial of BIIB092
The vice president and head of Alzheimer’s Disease, Dementia, and Movement Disorders in Late Stage Clinical Development at Biogen spoke about the upcoming TANGO II trial in Alzheimer disease.